beta
Trial Radar AI

Showing clinical trials matching location: Texas, United States.

I can help you find nearby clinical trials and understand health conditions and treatments.
63 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Location
Texas, United States
×
 
Study Type
Interventional
×
 
Intervention
GLP-1
×
 
Study Title
Status
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Not yet recruiting
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
Recruiting
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
Recruiting
Effect of Supplement on Appetite and GLP-1 (GLP-1 Suppleme) NCT06790771
Not yet recruiting
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass (GLP-1) NCT01803451
Recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes NCT05119179
Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
Avexitide for Treatment of Post-Bariatric Hypoglycemia (LUCIDITY) NCT06747468
Active, not recruiting
The Effects of Bariatric Surgeries on Glucose Metabolism NCT02823665
Recruiting
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
Active, not recruiting
Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men NCT07105826
Recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide (REMAIN-1) NCT06484114
Active, not recruiting
VK2735 for Weight Management Phase 3 (VANQUISH 1) NCT07104500
Active, not recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383
Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245
Not yet recruiting
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation (CLIN-GLP1) NCT07387796
Not yet recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder NCT07227948
Recruiting
Tirzepatide to Slow Biological Aging NCT07220473
Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults NCT06811324
Recruiting
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial NCT07505303
Not yet recruiting
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes NCT07284901
Recruiting
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes NCT07284979
Recruiting
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes NCT07284875
Recruiting
A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (EVOLVE-2) NCT07281937
Active, not recruiting
Aleniglipron Phase 2 Body Composition Study NCT07169942
Active, not recruiting
The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery NCT07212868
Recruiting
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity NCT06373146
Active, not recruiting
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874
Recruiting
A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity (ACCESS II) NCT06703021
Active, not recruiting
A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity (ACCESS) NCT06693843
Active, not recruiting
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes NCT06593314
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) NCT07165028
Recruiting
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study NCT06759701
Recruiting
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism NCT03941236
Active, not recruiting
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes NCT06246799
Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) NCT06857942
Recruiting
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes NCT06603571
Active, not recruiting
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (TOGETHER-PsA) NCT06588296
Active, not recruiting
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) NCT06864026
Recruiting
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight (TOGETHER-PsO) NCT06588283
Active, not recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight NCT06143956
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor NCT06221969
Active, not recruiting
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity (GYMINDA) NCT06965413
Active, not recruiting